Latest Health News
Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
MIAMI, May 08, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a…
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF)…
Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 07, 2026 19:07 ET | Source: Cue Biopharma, Inc. BOSTON, May…
Novi GLP-1 Weight Loss Claims Evaluated: Trusted Semaglutide & Tirzepatide Prescription Medication Treatment Options with Dedicated Doctors
Sheridan, WY, May 07, 2026 (GLOBE NEWSWIRE) -- Compounded medications are not…
SteelPower Male Enhancement Ingredient Research Gains Attention Amongst Men for Powerful Performance Support
Aurora, CO, May 06, 2026 (GLOBE NEWSWIRE) -- These statements have not…
Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated…
InnoCare Announces Approval of Clinical Trial of Novel CDH7 targeted ADC ICP-B208 in China
BEIJING, May 06, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE:…
Immutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary
Former Edgewise and Merck leader brings more than 15 years’ experience to…
Avactapresents new comparisons of pre|CISIONpayload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026
May 06, 2026 02:00 ET | Source: Avacta Group PLC LONDON and…
